203641 Sigma-AldrichBMP-2, Human, Recombinant, E. coli
Overview
| Replacement Information |
|---|
Key Spec Table
| Purity |
|---|
| ≥95% by SDS-PAGE |
| Product Information | |
|---|---|
| Form | Lyophilized |
| Formulation | Lyophilized from sterile 10 mM sodium citrate, pH 3.5. |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Purity | ≥95% by SDS-PAGE |
| Physicochemical Information |
|---|
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information |
|---|
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Catalogue Number | GTIN |
| 203641 | 0 |
Documentation
BMP-2, Human, Recombinant, E. coli SDS
| Title |
|---|
References
| Reference overview |
|---|
| Csiszar, A., et al. 2006. Am. J. Pathol. 168, 629. Kumagai, T., et al. 2006. Anticancer Res. 26, 293. Kumagai, T., et al. 2006. Int. J. Mol. Med. 17, 285. Kuo, P.L., et al. 2006. Biol. Pharm. Bull. 29, 119. Morin, R., et al. 2006. Biomacromolecules 7, 131. Villavicencio, A.T., et al. 2005. J. Neurosurg. Spine 3, 436. |



